†Plozasiran (ARO-APOC3), an Investigational RNAi, Demonstrates Robust and Durable TG Reductions in Patients with Mixed Dyslipidemia, MUIR Final Results
Titel:
†Plozasiran (ARO-APOC3), an Investigational RNAi, Demonstrates Robust and Durable TG Reductions in Patients with Mixed Dyslipidemia, MUIR Final Results
Auteur:
Vasas, Szilard Azizad, Masoud Clifton, Peter Rosenson, Robert Gaudet, Daniel Hellawell, Jennifer Chang, Ting Melquist, Stacey Fu, Ran Mushin, Ma'an Martin, Javier San Ballantyne, Christie